Skip to content

The Efficacy of Transversus Abdominis Plane Block Versus Wound Infiltration for Analgesia After Cesarean Delivery:

The Efficacy of Transversus Abdominis Plane Block Versus Wound Infiltration for Analgesia After Cesarean Delivery: (A Randomized Controlled Double-blinded Clinical Trial )

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04874168
Acronym
TAPBLOCK
Enrollment
210
Registered
2021-05-05
Start date
2021-01-01
Completion date
2022-06-30
Last updated
2022-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications

Brief summary

This study aimed to compare bilateral ultrasound-guided TAP block with single-shot local anesthetic wound infiltration for analgesia after cesarean delivery performed under spinal anesthesia

Detailed description

This double-blind, randomized controlled trial aimed to compare bilateral ultrasound-guided TAP block to single-shot local anesthetic wound infiltration for analgesia after cesarean delivery performed under spinal anesthesia. This will be done by measuring VAS (visual analogue score) for pain after ceserian section at2, 4, 6, 12, 24 hours .

Interventions

DEVICETAP block

bilateral ultrasound-guided TAP block was performed using a 12-4-MHz linear array transducer (ClearVue 350; Philips, Bothell, WA) placed transversely between the iliac crest and costal margin in the anterior axillary line and slid medial-lateral to visualize the external oblique, internal oblique, and trans-versus abdominis muscles; the most lateral (posterior) position obtaining a satisfactory ultrasound image was used

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

computer-generated table of random numbers

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Women undergoing cesarean section under spinal anesthesia * Aged ≥19 years and \> 40 years . * Gestational age ≥ 37 Weeks . * Informed Consent From the Patient .

Exclusion criteria

* Body mass index (BMI) ≥40 kg/m2 .. * History of recent opioid exposure . * Hypersensitivity to any of the drugs used in the study . * Significant cardiovascular, renal, or hepatic disease.

Design outcomes

Primary

MeasureTime frameDescription
The degree of pain at rest ;From 2 hours to 24 hours postoperativelyusing an Visual analogue scale (VAS) scores for pain intensity reported on 0-10 point scale for analysis. (0 = no pain and 10 = the worst possible pain) .

Secondary

MeasureTime frameDescription
The time to the first postoperative opioid doseat 2, 4, 6, and 12 hours.cumulative opioid consumption

Other

MeasureTime frameDescription
The degree of pain on movement (hip flexion and coughing)From 2 hours to 24 hours postoperativelyusing an Visual analogue scale (VAS) scores for pain intensity reported on 0-10 point scale for analysis. (0 = no pain and 10 = the worst possible pain) .

Countries

Egypt

Contacts

Primary ContactAhmed Gamal Elnajar, MD
a7medgamal2020.ag@gmail.com0201092672757

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026